Follow
Prof Dr Ibrahim Yildiz
Prof Dr Ibrahim Yildiz
Acibadem Üniversitesi Atakent Hastanesi
Verified email at acibadem.edu.tr
Title
Cited by
Cited by
Year
Performance status of patients is the major prognostic factor at all stages of pancreatic cancer
F Tas, F Sen, H Odabas, L Kılıc, S Keskın, I Yıldız
International journal of clinical oncology 18, 839-846, 2013
1142013
Depression, anxiety and sexual satisfaction in breast cancer patients and their partners-izmir oncology group study
A Alacacioglu, E Ulger, U Varol, I Yildiz, T Salman, V Bayoglu, A Dirican, ...
Asian Pacific Journal of Cancer Prevention 15 (24), 10631-10636, 2015
722015
Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival
F Tas, F Sen, S Keskin, L Kilic, I Yildiz
Molecular and clinical oncology 1 (4), 788-792, 2013
692013
Noncutaneous melanoma have distinct features from each other and cutaneous melanoma
F Tas, S Keskin, A Karadeniz, N Dağoğlu, F Sen, L Kilic, I Yildiz
Oncology 81 (5-6), 353-358, 2012
672012
Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon
H Apak, T Celkan, A Özkan, I Yildiz, EH Aydemir, S Ozdil, S Kuruoglu
Dermatology 208 (4), 345-348, 2004
652004
SURİYELİLERİN TÜRKİYE EKONOMİSİNDE KAYIT DIŞI İSTİHDAMA ETKİLERİ VE BUNUN YANSIMASI OLARAK TÜRKİYE’YE MALİYETLERİ ÜZERİNE BİR İNCELEME
T YILDIZ, İ YILDIZ
İktisadi İdari ve Siyasal Araştırmalar Dergisi 2 (3), 30-46, 2017
602017
Sexual satisfaction, anxiety, depression and quality of life among Turkish colorectal cancer patients [Izmir Oncology Group (IZOG) study]
M Akyol, E Ulger, A Alacacioglu, Y Kucukzeybek, Y Yildiz, V Bayoglu, ...
Japanese journal of clinical oncology 45 (7), 657-664, 2015
522015
Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer
F Tas, L Kilic, E Bilgin, S Keskin, F Sen, R Ciftci, I Yildiz, V Yasasever
International Journal of Gynecologic Cancer 23 (2), 2013
472013
Patterns of complementary and alternative medicine use among Turkish cancer patients
I Yildiz, M Ozguroglu, T Toptas, H Turna, F Sen, M Yildiz
Journal of palliative medicine 16 (4), 383-390, 2013
422013
The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in …
S Erdem, G Yegen, D Telci, I Yildiz, T Tefik, H Issever, I Kilicaslan, O Sanli
World journal of urology 33, 1553-1560, 2015
332015
D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients
L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ...
Cancer Biomarkers 15 (4), 405-411, 2015
312015
Sexual satisfaction, anxiety, depression and quality of life in testicular cancer survivors
A Alacacioglu, E Ulger, U Varol, T Yavuzsen, M Akyol, Y Yildiz, I Yildiz, ...
Medical Oncology 31, 1-6, 2014
302014
High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer
R Ciftci, F Tas, CT Yasasever, E Aksit, S Karabulut, F Sen, S Keskin, ...
Tumor Biology 35, 6941-6948, 2014
292014
Current adjuvant treatment modalities for gastric cancer: from history to the future
L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci
World journal of gastrointestinal oncology 8 (5), 439, 2016
282016
Impaired coronary flow reserve in metastatic cancer patients treated with sunitinib
F Sen, I Yildiz, M Basaran, M Ekenel, F Oz, L Kilic, B Toz, A Gurdal, ...
J BUON 18 (3), 775-81, 2013
282013
Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center.
T Basturk, Y Koc, A Unsal, E Ahbap, T Sakaci, I Yildiz, H Kayabasi, ...
European Review for Medical & Pharmacological Sciences 16 (12), 2012
282012
GLASS: Global Lorlatinib for ALK (+) and ROS1 (+) retrospective Study: real world data of 123 NSCLC patients
N Peled, R Gillis, S Kilickap, P Froesch, S Orlov, E Filippova, U Demirci, ...
Lung Cancer 148, 48-54, 2020
272020
Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy
N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ...
Medical Oncology 30, 1-6, 2013
262013
Prognostic value of mesothelin expression in patients with triple negative and HER2-positive breast cancers
IV Bayoglu, BB Kucukzeybek, Y Kucukzeybek, U Varol, I Yildiz, ...
Biomedicine & pharmacotherapy 70, 190-195, 2015
252015
The effects of adjuvant endocrine treatment on serum leptin, serum adiponectin and body composition in patients with breast cancer: The Izmir Oncology Group (IZOG) study
M Akyol, L Demir, A Alacacioglu, H Ellidokuz, Y Kucukzeybek, Y Yildiz, ...
Chemotherapy 61 (2), 57-64, 2016
212016
The system can't perform the operation now. Try again later.
Articles 1–20